Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 HKD | +2.08% | +15.75% | -55.72% |
Jun. 05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
Jun. 05 | Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates | MT |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- MarketScreener Editorial Features